ATE236646T1 - Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie - Google Patents

Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie

Info

Publication number
ATE236646T1
ATE236646T1 AT97946972T AT97946972T ATE236646T1 AT E236646 T1 ATE236646 T1 AT E236646T1 AT 97946972 T AT97946972 T AT 97946972T AT 97946972 T AT97946972 T AT 97946972T AT E236646 T1 ATE236646 T1 AT E236646T1
Authority
AT
Austria
Prior art keywords
leukemia
mammal
reactive oxygen
malignant cells
compounds
Prior art date
Application number
AT97946972T
Other languages
English (en)
Inventor
Lisa Marlene Jeffreys Smith
Original Assignee
Lisa Marlene Jeffreys Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisa Marlene Jeffreys Smith filed Critical Lisa Marlene Jeffreys Smith
Application granted granted Critical
Publication of ATE236646T1 publication Critical patent/ATE236646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97946972T 1996-12-03 1997-12-02 Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie ATE236646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3233296P 1996-12-03 1996-12-03
PCT/CA1997/000930 WO1998024456A1 (en) 1996-12-03 1997-12-02 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia

Publications (1)

Publication Number Publication Date
ATE236646T1 true ATE236646T1 (de) 2003-04-15

Family

ID=21864379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946972T ATE236646T1 (de) 1996-12-03 1997-12-02 Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie

Country Status (7)

Country Link
US (1) US6399664B2 (de)
EP (1) EP0951288B1 (de)
AT (1) ATE236646T1 (de)
AU (1) AU5218998A (de)
CA (1) CA2274461A1 (de)
DE (1) DE69720783D1 (de)
WO (1) WO1998024456A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US20050051497A1 (en) * 2003-07-31 2005-03-10 Latino Joseph S. Viral inactivation using ozone
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20070128241A1 (en) * 2003-10-03 2007-06-07 Judith Boston Methods, compositions, apparatuses containing tetrameric oxygen
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
US8066659B2 (en) 2004-06-15 2011-11-29 Ceramatec, Inc. Apparatus and method for treating and dispensing a material into tissue
US8777889B2 (en) * 2004-06-15 2014-07-15 Ceramatec, Inc. Apparatus and method for administering a therapeutic agent into tissue
JP4384208B2 (ja) * 2007-07-20 2009-12-16 シャープ株式会社 外添剤の評価方法、トナーの評価方法
US10335538B2 (en) * 2015-12-08 2019-07-02 Priya Visweswaran Balakrishnan System and treatment method to increase circulation and pluripotency of stem and progenitor cells within a patient
US20170157317A1 (en) * 2015-12-08 2017-06-08 Priya Visweswaran Balakrishnan Treatment Method to Cure Diseases Within a Patient by Administering Intravenous Oxygen Mixtures

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632980A (en) 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE3940389A1 (de) * 1989-12-06 1991-06-13 Abolghassem Prof Dr M Pakdaman Therapeutisches mittel
US5622848A (en) * 1990-05-23 1997-04-22 Medical Discoveries, Inc. Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood
DE4100782A1 (de) * 1991-01-12 1992-07-16 Patentverwertung Dr J Haensler Waessrige ozonpraeparate, verfahren zu ihrer herstellung und ihre verwendung
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
EP0951288B1 (de) 2003-04-09
US6399664B2 (en) 2002-06-04
EP0951288A1 (de) 1999-10-27
AU5218998A (en) 1998-06-29
CA2274461A1 (en) 1998-06-11
DE69720783D1 (de) 2003-05-15
WO1998024456A1 (en) 1998-06-11
US20010049395A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
ATE236646T1 (de) Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
ATE296839T1 (de) Antikörper zur krebsbehandlung und -diagnose
ES2006776A6 (es) Un procedimiento para producir una proteina il-6.
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
Trulson et al. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer
ATE253117T1 (de) Adenovirus e4 proteine für induktion von zelltod
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
AU5827080A (en) 6-substituted-11-alkylene morphanthridines
DE3879575D1 (de) Alpha-carotin zur wachstumshemmung von krebszellen.
ATE78164T1 (de) Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie.
GB2226494B (en) Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
GB2213373B (en) Po-man's photosynthesis in men's blood to cure cancer (phmdcc)
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
SE8604587D0 (sv) Lekemedelssats for sarlekningsstimulering samt sett att anvenda och tillverka satsen
IT1274592B (it) Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
MX9708989A (es) Terapia de celulas alogeneicas para el cancer despues del transplante de celulas madre alogeneicas.
NZ506005A (en) Recombinant proteins derived from hgf and msp
ES2165366T3 (es) Procedimientos y composiciones para inhibir la inflamacion mediada por celulas endoteliales y fibrinogeno.
RU96102282A (ru) Способ терапии поллиноза
EP0278715A3 (de) Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
NZ218540A (en) Azapropazone treatment of mammals
MX9701832A (es) Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties